QQQ   425.93 (+0.02%)
AAPL   167.55 (-0.27%)
MSFT   408.78 (-0.74%)
META   508.87 (+2.97%)
GOOGL   156.46 (+0.64%)
AMZN   181.63 (+0.19%)
TSLA   149.90 (-3.57%)
NVDA   857.48 (+2.04%)
AMD   155.76 (+1.13%)
NIO   4.01 (+2.56%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.09 (+0.42%)
MU   112.47 (-3.32%)
GE   156.70 (+0.66%)
CGC   7.75 (+19.41%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.31 (-0.43%)
PYPL   62.50 (-1.20%)
XOM   118.93 (+0.25%)
QQQ   425.93 (+0.02%)
AAPL   167.55 (-0.27%)
MSFT   408.78 (-0.74%)
META   508.87 (+2.97%)
GOOGL   156.46 (+0.64%)
AMZN   181.63 (+0.19%)
TSLA   149.90 (-3.57%)
NVDA   857.48 (+2.04%)
AMD   155.76 (+1.13%)
NIO   4.01 (+2.56%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.09 (+0.42%)
MU   112.47 (-3.32%)
GE   156.70 (+0.66%)
CGC   7.75 (+19.41%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.31 (-0.43%)
PYPL   62.50 (-1.20%)
XOM   118.93 (+0.25%)
QQQ   425.93 (+0.02%)
AAPL   167.55 (-0.27%)
MSFT   408.78 (-0.74%)
META   508.87 (+2.97%)
GOOGL   156.46 (+0.64%)
AMZN   181.63 (+0.19%)
TSLA   149.90 (-3.57%)
NVDA   857.48 (+2.04%)
AMD   155.76 (+1.13%)
NIO   4.01 (+2.56%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.09 (+0.42%)
MU   112.47 (-3.32%)
GE   156.70 (+0.66%)
CGC   7.75 (+19.41%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.31 (-0.43%)
PYPL   62.50 (-1.20%)
XOM   118.93 (+0.25%)
QQQ   425.93 (+0.02%)
AAPL   167.55 (-0.27%)
MSFT   408.78 (-0.74%)
META   508.87 (+2.97%)
GOOGL   156.46 (+0.64%)
AMZN   181.63 (+0.19%)
TSLA   149.90 (-3.57%)
NVDA   857.48 (+2.04%)
AMD   155.76 (+1.13%)
NIO   4.01 (+2.56%)
BABA   69.29 (+0.68%)
T   16.20 (+0.50%)
F   12.09 (+0.42%)
MU   112.47 (-3.32%)
GE   156.70 (+0.66%)
CGC   7.75 (+19.41%)
DIS   113.60 (+0.58%)
AMC   2.92 (-2.01%)
PFE   25.31 (-0.43%)
PYPL   62.50 (-1.20%)
XOM   118.93 (+0.25%)
Free Trial
CVE:VPT

VentriPoint Diagnostics (VPT) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)
Free VPT Stock Alerts
C$0.22
+0.01 (+2.38%)
(As of 12:06 PM ET)
Compare
Today's Range
C$0.22
▼
C$0.22
50-Day Range
C$0.21
▼
C$0.32
52-Week Range
C$0.12
▼
C$0.36
Volume
120,500 shs
Average Volume
99,421 shs
Market Capitalization
C$33.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesInsider Trades
VPT stock logo

About VentriPoint Diagnostics Stock (CVE:VPT)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

VPT Stock Price History

VPT Stock News Headlines

April 17, 2024 | americanbankingnews.com
VentriPoint Diagnostics (CVE:VPT) Trading Up 4.8%
April 14, 2024 | morningstar.com
VentriPoint Diagnostics Ltd VPT
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
March 28, 2024 | finance.yahoo.com
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
March 4, 2024 | stockhouse.com
Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use
February 21, 2024 | benzinga.com
VentriPoint Diagnostics Stock (OTC:VPTDF) Dividends: History, Yield and Dates
February 14, 2024 | morningstar.com
VentriPoint Diagnostics Ltd VPTDF
February 13, 2024 | stockhouse.com
Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
February 1, 2024 | es-us.finanzas.yahoo.com
The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System
January 29, 2024 | finance.yahoo.com
The 2023 Year in Review
December 12, 2023 | theglobeandmail.com
Healthcare Stock Rallies Strongly Following Key Implementation
December 5, 2023 | finance.yahoo.com
Ollie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's Hospitals
November 5, 2023 | morningstar.com
Accelerate Diagnostics Inc AXDX
October 4, 2023 | seekingalpha.com
Ventripoint Diagnostics appoints Jimmy Jeon as CFO
August 31, 2023 | seekingalpha.com
VentriPoint Diagnostics reports Q2 results
August 22, 2023 | finance.yahoo.com
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
August 18, 2023 | finance.yahoo.com
Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular
August 10, 2023 | finance.yahoo.com
Ventripoint Announces Collaboration with Ascend Cardiovascular
July 18, 2023 | finance.yahoo.com
Ventripoint's VMS+ Purchased by Medical Center - University of Freiburg
July 15, 2023 | theglobeandmail.com
Closing Bell: Ventripoint Diagnostics Ltd flat on Friday (VPT)
May 23, 2023 | ca.finance.yahoo.com
VentriPoint Diagnostics Ltd. (VPTDF)
May 2, 2023 | theglobeandmail.com
Closing Bell: Ventripoint Diagnostics Ltd down on Monday (VPT)
April 29, 2023 | theglobeandmail.com
Closing Bell: Ventripoint Diagnostics Ltd up on Friday (VPT)
April 28, 2023 | theglobeandmail.com
Closing Bell: Ventripoint Diagnostics Ltd down on Thursday (VPT)
April 27, 2023 | theglobeandmail.com
Closing Bell: Ventripoint Diagnostics Ltd up on Wednesday (VPT)
April 25, 2023 | theglobeandmail.com
Closing Bell: Ventripoint Diagnostics Ltd flat on Tuesday (VPT)
See More Headlines
Receive VPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Next Earnings (Estimated)
5/02/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
CVE:VPT
CUSIP
N/A
CIK
N/A
Web
www.ventripoint.com
Phone
416-848-4156
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-4,740,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.63%
Return on Assets
-63.46%

Debt

Debt-to-Equity Ratio
32.61
Current Ratio
2.06
Quick Ratio
6.67

Sales & Book Value

Annual Sales
C$24,600.00
Price / Sales
1,370.58
Cash Flow
C$0.04 per share
Price / Cash Flow
5.53
Book Value
C$0.01 per share
Price / Book
21.50

Miscellaneous

Outstanding Shares
156,820,000
Free Float
N/A
Market Cap
C$33.72 million
Optionable
Not Optionable
Beta
0.39
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. George Adams B.A.Sc. (Age 76)
    ICD.D., M.A.Sc., Ph.D., Executive Chairman & Corporate Secretary
    Comp: $286k
  • Mr. Hugh MacNaught
    Interim CEO, President & Director
  • Mr. Jimmy Jeon
    Chief Financial Officer
  • Mr. Hirotaka Katagiri
    CTO & Business Development Division Director
  • Mr. Jim Graba
    Application Specialist & Chief Trainer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

VPT Stock Analysis - Frequently Asked Questions

How have VPT shares performed in 2024?

VentriPoint Diagnostics' stock was trading at C$0.30 on January 1st, 2024. Since then, VPT shares have decreased by 27.1% and is now trading at C$0.22.
View the best growth stocks for 2024 here.

When is VentriPoint Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our VPT earnings forecast.

What other stocks do shareholders of VentriPoint Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VentriPoint Diagnostics investors own include Resverlogix (RVX), AuRico Gold Inc. Ordinary Share (AUQ), Kootenay Silver (KTN), ProMetic Life Sciences (PLI), Shopify (SHOP), Shockwave Medical (SWAV), Barkerville Gold Mines Ltd. (BGM.V) (BGM), Bird Construction (BDT), Bombardier, Inc. Class B (BBD.B) and

How do I buy shares of VentriPoint Diagnostics?

Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:VPT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Paradigm Press
The Next Nvidia?
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Urgent alert: open this for a huge profit potential
Timothy Sykes